Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder
17 janv. 2019 09h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for...
Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series
15 janv. 2019 09h05 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of...
Update: Adial Pharmaceuticals to Present at The 2019 Wall Street Conference
10 janv. 2019 10h24 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals to Present at The 2019 Wall Street Conference
10 janv. 2019 08h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Retires All Outstanding Debt
24 déc. 2018 08h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL;ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group
19 déc. 2018 09h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
13 déc. 2018 08h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder
10 déc. 2018 08h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused on the development of...
Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder
29 nov. 2018 09h10 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Chairman Featured in Doctors Channel Video Discussing Alcohol Use Disorder
21 nov. 2018 08h00 HE
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...